Sectors
MPLT
MapLight Therapeutics, Inc.
36.98
1 x 36.53
1 x 37.42
bid
ask
-
0.46
1.23%
10:04 AM
timesize
| Ytd | 110.47% | |
| 1y | 101.64% |
36.31
day range
37.70
12.24
52 week range
40.43
| Open | 37.70 | Prev Close | 37.44 | Low | 36.31 | High | 37.70 | Mkt Cap | 29.55M |
| Vol | 21.23K | Avg Vol | 422.82K | EPS | -38.52 | P/E | -0.97 | Forward P/E | -10.51 |
| Beta | N/A | Short Ratio | 5.58 | Inst. Own | 56.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 31.66 | 200-d Avg | 22.78 | 1yr Est | 41.50 |
| Income Statement | |||
| Operating Expenses | 64.50M | ||
| Research and Development Expense | 53.68M | ||
| Selling, General and Administrative Expense | 10.82M | ||
| Operating Income | -64.50M | ||
| Net Income | -60.67M | ||
| Net Income Common Stock | -60.67M | ||
| Net Income Common Stock (USD) | -60.67M | ||
| Consolidated Income | -60.67M | ||
| Earnings per Basic Share | -1.34 | ||
| Earnings per Basic Share (USD) | -1.34 | ||
| Earnings per Diluted Share | -1.34 | ||
| Earning Before Interest & Taxes (EBIT) | -60.67M | ||
| Earning Before Interest & Taxes (USD) | -60.67M | ||
| Weighted Average Shares | 45.28M | ||
| Weighted Average Shares Diluted | 45.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.91M | ||
| Cash and Equivalents (USD) | 55.91M | ||
| Investments | 339.50M | ||
| Investments Current | 254.41M | ||
| Investments Non-Current | 85.09M | ||
| Current Assets | 327.23M | ||
| Property, Plant & Equipment Net | 6.23M | ||
| Total Assets | 418.79M | ||
| Debt Current | 920.00K | ||
| Total Debt | 5.59M | ||
| Current Liabilities | 14.28M | ||
| Debt Non-Current | 4.67M | ||
| Total Liabilities | 18.95M | ||
| Accumulated Retained Earnings (Deficit) | -421.19M | ||
| Accumulated Other Comprehensive Income | -883.00K | ||
| Shareholders Equity | 399.83M | ||
| Shareholders Equity (USD) | 399.83M | ||
| Assets Non-Current | 91.56M | ||
| Total Debt (USD) | 5.59M | ||
| Liabilities Non-Current | 4.67M | ||
| Trade and Non-Trade Payables | 3.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 391.00K | ||
| Net Cash Flow from Financing | -6.85M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.98M | ||
| Capital Expenditure | -24.00K | ||
| Issuance (Purchase) of Equity Shares | 651.00K | ||
| Net Cash Flow from Investing | 67.01M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 67.03M | ||
| Net Cash Flow from Operations | -51.18M | ||
| Share Based Compensation | 9.64M | ||